about
Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review.Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.Validity of The Health Improvement Network (THIN) for the study of psoriasis.The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials.Briakinumab.The diagnostic challenge of vulvar squamous cell carcinoma: Clinical manifestations and unusual human papillomavirus typesAlcohol-induced vasculitis: case report and commentary.Antibiotic sensitivity and resistance patterns in pediatric staphylococcal scalded skin syndrome.Persistence of mild to moderate atopic dermatitis.Human herpesvirus 6 involvement in paediatric drug hypersensitivity syndrome.Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patientsDermatologist response rates to a mailed questionnaire: a randomized trial of monetary incentives.Association Between Malignancy and Topical Use of Pimecrolimus.Atopic dermatitis disease control and age: A cohort study.Dermatologist preferences for treatments to compare in future randomized controlled comparative effectiveness trials for moderate to severe psoriasisVariation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasisReliability and validity of a photographic method for measuring facial hair density in menA randomized, double-blind, placebo-controlled proof of concept trial of topical cidofovir, 1% and 3%, for the prevention of beard hair growth in men.The role of systematic reviews and meta-analysis in dermatology.Mucinous nevus: report of a case and review of the literature.Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).Pharmacy provision of medical abortifacients in a Latin American city.Abuse during pregnancy in Mexico City.Association Between Leukemia and Topical Use of Pimecrolimus-Reply.Databases for Clinical Research.Comparisons of patients' satisfaction should take expectations into account.Do children really outgrow their eczema, or is there more than one eczema?The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study.Physicians' knowledge and opinions about medication abortion in four Latin American and Caribbean region countries.Conclusions about atopic dermatitis persistence might be premature.The prevalence of atopic dermatitis beyond childhood: A systematic review and meta-analysis of longitudinal studies.Systematic review of atopic dermatitis disease definition in studies using routinely-collected health data.Risk of pregnancy and external validity in clinical trials of emergency contraception.Is new better than tried and tested? Topical atopic dermatitis treatment in context.Association of systemic psoriasis therapies and incidence of myocardial infarction: reply from authorsBarriers to contraceptive use in product labeling and practice guidelinesAs often as needed: appropriate use of emergency contraceptive pillsOral contraceptives for acne and sexual practicesA multiyear cross-sectional study of U.S. national prescribing patterns of first-generation sedating antihistamines in older adults with skin diseaseWhy does the BJD require registration of systematic reviews and meta-analyses?
P50
Q30248500-FA8FD722-13ED-4C8F-866E-4505302E8B5AQ34253312-AFBA7532-A165-4099-AA34-8BD80317BFBFQ34721703-F9AADAB9-DC46-4C1E-B641-4CABDB40EC91Q34984568-6FEE7FCB-D298-425A-915A-5444970D180DQ34990097-242A7119-B17B-4EF5-AC5F-B49D55B0D737Q35146539-62D955F0-C3D0-49FF-810D-6399528149D6Q35146551-3C3488DC-1B96-4568-9B5D-85F0D262E820Q35146555-63C5A23D-837B-47D0-A90B-CF18211648F9Q35155669-638C5562-1469-4161-938B-0C14ADB85F48Q35243378-B864C139-CF6E-4FD5-A5B2-51D914FCD28BQ35571621-A5973F7F-4D62-417C-A8F1-570DDA7218EBQ35624266-0C735EB3-1852-4976-BF78-416B40A39463Q35733343-D462F703-3F95-472E-A7A8-35BF4A52AAB9Q35828352-8DE0EDF6-D3B5-46C2-9E5C-54267AD1E6A3Q35910822-7D744CC6-1726-4417-BD3E-6B93CD6A7A19Q36816617-BD7FF006-570E-46A5-972C-F59D6194DD2CQ36913190-922BC730-31B6-441D-AF0A-7859C9C7B39BQ36914918-C4F437F4-5111-491D-9CDD-0B3F2FFF3197Q38052360-9B9ADE93-C983-4FEA-9063-3628C98B890BQ38230147-7814DD86-9A6D-4721-A3AD-2BF904029855Q39582913-BDFCCD23-53C5-480D-A937-254779CF24E2Q39771926-61284B0F-24A6-44E4-B190-B8D9482DE629Q39787153-FE3A1B9C-5BE7-431C-92B8-203321537583Q41064458-FBC446E1-002A-4890-965E-167354F6F854Q41586986-ADE0CCC5-735F-410D-8B06-EEFE245CF952Q42493444-9EC8F8E5-9731-4745-A3F2-3F61AB7E1661Q43036136-B4F096A6-62BF-45CE-90C3-E18245B0FF7AQ43760972-3876047D-B8EE-42BB-9BCF-C52907443573Q45003031-30A236EC-3E03-4279-BB84-2271D36BF3EEQ46188187-8C75FF28-5665-48CC-8B45-6E6C1367A766Q46847737-0E3CA8BD-9496-49D2-8B36-8209039D2429Q47559176-EB328C73-BC71-4A5E-88DC-17B9383D135DQ50106955-60FA36D1-5A25-4A55-A6A6-B4D53A892E98Q52623234-40A781C8-5E18-4CF6-9945-4C7B5041808AQ60220823-45036B2E-18D5-4D08-BB09-5CED20FD8059Q60220831-43A347A9-7CEE-43A9-AE81-0CCB0A6DBC88Q60220833-83E63833-502B-48ED-81A8-BD689A6480FEQ60236415-4D41F740-07DE-4100-9112-595E1614FCECQ90300640-34B8447B-8B0B-46FF-BD56-7EA4579EF83BQ91325099-8DDFC34A-7735-4BAF-A142-E665F06930C9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Katrina Abuabara
@ast
Katrina Abuabara
@en
Katrina Abuabara
@es
Katrina Abuabara
@nl
Katrina Abuabara
@sl
type
label
Katrina Abuabara
@ast
Katrina Abuabara
@en
Katrina Abuabara
@es
Katrina Abuabara
@nl
Katrina Abuabara
@sl
prefLabel
Katrina Abuabara
@ast
Katrina Abuabara
@en
Katrina Abuabara
@es
Katrina Abuabara
@nl
Katrina Abuabara
@sl
P106
P21
P31
P496
0000-0002-7736-6946